ibrutinib
janssen,abbvie
['congrat', 'cml', 'ibru']
congrats to dr eva gin for her oral presentation at #17icml! five-year update of the first-line imcl-2015 study. prolonged molecular and clinical responses were observed after mrd-driven ibrutinib discontinuation ( abstract #98) 
MD at @USAL | Internal Med student at @HematoCAUSA | #cytopath #cytometry and #lymphoma at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes